Concentra Group Valuation
| CON Stock | 22.82 -0.18 -0.78% |
Below Model Estimate
Today
Please note that Concentra Group's price fluctuation is Very Low at this time. This valuation view for Concentra Group Holdings reflects a 3 months time horizon. Without a positive trailing P/E, the market views earnings stability as unproven, which can push pricing below model-derived estimates. Extending Concentra Group's horizon generally improves valuation accuracy.
Value Estimates Divergence
Market pricing at $22.82 versus a model-derived intrinsic value estimate near $32.77 per share indicates Concentra Group is reading as below model estimate. The valuation for Concentra Group draws on a return on equity of 27%, a profit margin of 11%, and current valuation of $4.96B, with context from risk profile.| Historical | Market 22.82 | Intrinsic 32.77 | Target 29.0 | Sentiment 22.87 | Naive 22.98 | DCF 39.71 |
Estimating the intrinsic value of Concentra Group starts with Concentra Group's forward earnings trajectory and the discount rate that reflects its risk profile. Since Concentra Group is exchange-traded, market price reflects real-time supply and demand — intrinsic value reflects the underlying economics. Assessing the intrinsic value estimate means looking beyond short-term price movements to long-term earnings power. Common methods to calculate Concentra Group's intrinsic value include discounted cash flow and comparable company multiples.
Accurately estimating the upside and downside potential of Concentra Group Holdings is critical for allocation decisions. The spread between upside and downside reflects the degree of uncertainty the market is pricing into Concentra Group's earnings trajectory. Scenario-based ranges are more useful than point estimates because they expose the assumptions behind the valuation. The upside and downside estimates are model-dependent and should be treated as scenario boundaries, not price targets.
For Concentra Group, intrinsic valuation discounts forecasted free cash flows at the weighted average cost of capital. Discounted cash flow, comparable company multiples, and asset-based valuation each capture different dimensions. The reliability of any Concentra Group valuation depends on the quality of its inputs and assumptions. Using multiple methods, adjusting for market conditions, and benchmarking against peers produces the best estimate.
Main Profitability Drivers
The latest figures show Concentra Group's net profit margin at 11.00% and operating margin at 101.00%. The 90.00 percentage-point gap between operating and net margins points to non-operating costs such as interest expense or taxes reducing bottom-line profitability. On 2.16 Billion of revenue, Concentra Group earned 613.09 Million in gross profit and 172.8 Million on the bottom line. The company produces 27.00% on shareholders' equity and 7.37% on total assets, framing Concentra Group's capital efficiency picture. Some profitability measures for Concentra Group are trending positively while others remain under pressure, calling for closer scrutiny. A more granular view is available in Concentra Group's profitability metrics for a broader perspective on earnings quality.
Price Book 7.4566 | Gross Profit | Price Sales 1.3555 | Profit Margin | Enterprise Value Revenue 2.2905 |
Concentra Group Cash | 91.35 Million |
Cash stood at 79.9 Million as of December 31, 2025.
Concentra Group operates as a medical equipment provider generating revenue through device sales, innovation, and healthcare demand. Positioned as a diversified stock within Health Care Providers & Services, it shows a balanced mix of valuation characteristics in its current profile. What follows breaks down capital structure, margins, and earnings quality to assess whether current pricing is supported by fundamentals.
Total Value Analysis
Concentra Group Holdings currently shows enterprise value of 4.96 B, market capitalization of 2.93 B, debt of 2.1 B, and cash and equivalents of n/a as of latest reporting. In practice, enterprise value isolates the operating business from capital-structure noise, but only holds if the underlying debt and cash figures are stable.| Takeover Price | Market Cap | Debt Obligations | Cash & Equivalents |
4.96 B | 2.93 B | 2.1 B |
Investor Information
About 89.0% of the company shares are held by institutions such as insurance companies. The company had its last dividend issued on the 12th of March 2026. Concentra Group financial strength assessment points to stable financial positioning. Profitability levels reflect stable operating returns across recent reporting periods.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 1.01 | 0.965 |
|
| |||||
| Total Cash From Operating Activities | 216.5 M | 279.4 M |
|
| |||||
| Operating Income | 2.2 B | 2.1 B |
|
|
Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Concentra Group has an asset utilization ratio of 71.21 percent. This suggests that the Company is making USD0.71 for each dollar of assets. An increasing asset utilization means that Concentra Group Holdings is more efficient with each dollar of assets it utilizes for everyday operations.Macro event markers
Discounted Cash Flow Analysis
Concentra Group Holdings screens below its custom levered DCF estimate, with implied equity value per share of 39.71 against a market price of 22.82. That leaves the shares trading about 74.0% below this model output. The setup uses a WACC of 6.16% and a long-term growth rate of 2.0%, with next-period free cash flow around 331.13 Million. Discounted forecast cash flows sum to about 1.21 Billion before the terminal component, and present terminal value still represents roughly 83.0% of enterprise value. With 83.0% of enterprise value concentrated in the terminal component, the estimate is inherently assumption-sensitive and should be interpreted as directional rather than precise.Model Value / Share
39.71
Equity value per share from the current custom levered DCF summary row.
Market Price
22.82
Current market price used by the same scenario.
Model Upside
74.0%
Market price sits below the model output.
WACC / LT Growth
6.16% / 2.0%
Forecast horizon: 2021 to 2030Terminal value share of EV: 83.0%
Concentra Market Price vs. Intrinsic Value
This chart compares observed market pricing with the model-derived equity value per share across forecast periods. It also illustrates the relative premium or discount, expressed as a percentage difference between market valuation and modeled intrinsic value.
Projected Revenue and Levered Free Cash Flow
Revenue and levered free cash flow projections are presented in billions, outlining the expected financial trajectory over the modeled horizon.
Key Model Assumptions
The inputs below reflect the core assumptions applied in the valuation model, including growth expectations, discount rates, and capital structure considerations.
| Input | Current Value |
|---|---|
| Weighted Average Cost of Capital | 6.16% |
| Long-Term Growth Rate | 2.0% |
| Cost of Equity | 7.80% |
| After-Tax Cost of Debt | 4.01% |
| Debt Weighting | 41.82% |
| Equity Weighting | 58.18% |
| Net Debt | 2.02 Billion |
| Enterprise Value | 7.11 Billion |
| Present Terminal Value | 5.9 Billion |
| Terminal Value Share of EV | 83.0% |
Forecast Detail and Valuation Progression
This table presents the underlying forecast data used in the valuation, including revenue, cash flow generation, discounting effects, and the resulting per-share value across each projected period.
| Year | Revenue | Revenue Growth | Free Cash Flow | PV of LFCF | Equity Value / Share |
|---|---|---|---|---|---|
| 2021 | 1.73 Billion | 0.00% | 243.85 Million | 0.0 | 39.66 |
| 2022 | 1.72 Billion | -0.44% | 228.35 Million | 0.0 | 39.73 |
| 2023 | 1.84 Billion | 6.60% | 164.98 Million | 0.0 | 39.73 |
| 2024 | 1.9 Billion | 3.38% | 210.35 Million | 0.0 | 39.84 |
| 2025 | 2.16 Billion | 13.85% | 197.06 Million | 0.0 | 39.59 |
| 2026 | 2.29 Billion | 5.85% | 258.64 Million | 243.63 Million | 39.71 |
| 2027 | 2.42 Billion | 5.85% | 273.76 Million | 242.91 Million | 39.71 |
| 2028 | 2.57 Billion | 5.85% | 289.77 Million | 242.19 Million | 39.71 |
| 2029 | 2.72 Billion | 5.85% | 306.71 Million | 241.47 Million | 39.71 |
| 2030 | 2.87 Billion | 5.85% | 324.63 Million | 240.75 Million | 39.71 |
Profitability Analysis
Reviewing Concentra Group's reported profitability metrics, Concentra Group Holdings is profitable with a net margin of 11.0% and operating margin of 101.0%, reporting net income of 172.8 Million. Return on equity stands at 27.0%. Profitability trends are stable, with recent metrics holding near prior-year levels.Net Income | First Reported 2010-12-31 | Previous Quarter 172.8 M | Current Value 172.8 M | Quarterly Volatility 21.4 M |
Macro event markers
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.21 | 0.2834 |
|
| |||||
| Net Profit Margin | 0.11 | 0.0799 |
|
| |||||
| Operating Profit Margin | 1.01 | 0.965 |
|
| |||||
| Pretax Profit Margin | 0.14 | 0.1034 |
|
| |||||
| Return On Assets | 0.0737 | 0.0569 |
|
| |||||
| Return On Equity | 0.27 | 0.4394 |
|
|
Concentra Group profitability is assessed through margins, return on equity, and asset efficiency. Net margin of 11.0% is adequate, though not at levels that typically signal strong pricing power. What follows tests whether current margins and returns are sustainable under prevailing business conditions. Concentra Group reports return on equity of 27.0%, above the level typically associated with durable competitive advantages.
Earnings per Share Projection vs Actual
EPS projections for Concentra Group aggregate analyst models into a benchmark against which actual results are measured. Return on equity of 48.07% provides context for how efficiently Concentra Group generates earnings from shareholder capital. The gap between Concentra Group's EPS and free cash flow per share signals how much of reported earnings converts to cash. Concentra Group's EPS estimates are updated as new analyst reports and company disclosures become available. The EPS consensus for Concentra Group Holdings reflects normalized analyst expectations. Comparing this estimate against the current net margin profile (11.0%), guidance revisions, and prior forecast error reveals whether the market is pricing in improvement, stability, or deterioration. Concentra Group reported estimated earnings of 0.3384 in earnings per share on 31st of March 2026. The strongest signal comes from comparing this forecast against the company's historical beat/miss rate and recent guidance revisions.Macro event markers
Ownership Allocation
The majority of Concentra Group's outstanding shares are owned by institutional investors. These positions are typically held by large asset managers, pension funds, and index funds that manage capital on behalf of millions of clients. Institutions of this scale are required to disclose their holdings through 13F filings with the SEC, providing visibility into ownership changes each quarter.Revenue and Profit Overview
The company reported last year's revenue of 2.16 B. Total Income to common stockholders was 172.8 M with profit before taxes, overhead, and interest of 613.09 M.Past Distributions to Stockholders
Analyzing how the company distributes profits can provide insight into shareholder return strategy. Investors often compare dividend payments with profitability and free cash flow trends. Income-focused investors may want to check historical dividend payments.
| 19th of March 2026 | ||
| 9th of December 2025 | ||
| 28th of August 2025 | ||
| 29th of May 2025 | ||
| 1st of April 2025 | ||
| 22nd of November 2024 |
What the Data Shows
Margins of 11.0% are adequate but not exceptional - competitive dynamics or cost shifts in either direction could move the profitability picture meaningfully. The 27.0% return on equity indicates efficient use of shareholder capital, a metric that typically correlates with durable competitive positioning in Health Care Providers & Services.
Combined Signal Overview
Concentra Group Holdings fits the profile of an asset-light business model with strong pricing power and limited dependence on balance sheet leverage, a positioning that shapes how Health Care Providers & Services are valued. Both profitability and capital efficiency sit above sector norms, reflecting structural advantages in pricing or cost structure. At current levels, Concentra Group's valuation reflects an earnings profile that has not yet stabilized. A re-rating would require demonstrated improvement in profitability and cost discipline.
These valuation inputs for Concentra Group Holdings should be revisited as new filings and market data become available. Given the current mix of multiples, margins, and leverage, the valuation picture is most useful when tracked over time rather than read as a static conclusion.
Valuation Framework, Methodology & Assumptions
Concentra Group is a mid-cap equity in Health Care Providers & Services, Health Care Equipment & Services, Health Care categories. Profitability trends drive pricing sustainability. For Concentra Group, P/B of 7.46 anchors the current valuation read, with P/S of 1.36, enterprise value of 4.96 B adding context.
Reported values for Concentra Group Holdings are derived from periodic company reporting and market reference feeds and standardized for analysis. Valuation outputs are model-derived and depend on published assumptions and reference inputs.
The analysis above is generated by quantitative models and is provided for informational and educational purposes only. It does not constitute financial advice, investment recommendations, or an endorsement to buy or sell any security. All investing involves risk, including the possible loss of principal. Consult a qualified financial advisor before making investment decisions. See our Terms of Use for full details.
Financial data referenced in this analysis is derived from publicly available SEC filings, audited financial statements, and third-party market data providers. The intrinsic value estimate is generated by Macroaxis quantitative models that incorporate fundamental analysis, technical indicators, and risk metrics.
The methodology combines multiple analytical inputs:
- Fundamental analysis - financial statements, profitability ratios, debt structure, and cash flow metrics sourced from SEC filings and public financial reports
- Technical indicators - historical price patterns, momentum signals, and volatility measures
- Risk assessment - probability of bankruptcy models, market risk metrics, and downside scenario analysis
- Peer comparison - relative valuation against industry peers using standardized multiples
Model outputs are refreshed periodically as new financial data becomes available. Past model performance is not indicative of future results. The intrinsic value estimate reflects a point-in-time calculation and should be considered alongside other research and professional advice.
Data sourced from SEC filings (EDGAR), public financial statements, and market data providers.
Editorial review and methodology oversight provided by: Gabriel Shpitalnik, Member of Macroaxis Editorial Board
Growth Indicators
When investors treat Concentra Group Holdings as a growth opportunity, they are usually paying for future execution rather than only for current fundamentals. In practice, growth analysis separates durable compounding from optimism that may already be fully priced in.
| Common Stock Shares Outstanding | 128.2 M | |
| Quarterly Earnings Growth Y O Y | 60.10% | |
| Forward Price Earnings | 15.949 |
Concentra Group Current Valuation Indicators
The intrinsic value of Concentra Group Holdings is estimated using multiple approaches, including discounted cash flow analysis, relative valuation multiples, and balance sheet-based methods, each reflecting different assumptions about earnings durability, capital structure, and future cash generation. The key question is comparative: what does the market charge per dollar of revenue, profit, and assets, and is that justified? Reported values are derived from company filings, audited financial statements, and market data, and are standardized within Macroaxis quantitative models for consistency. Model outputs reflect a point-in-time estimate based on available data and assumptions and should be interpreted alongside changes in operating performance, market conditions, and forward expectations.